-
UK hosts national meeting to raise immunization rate for vaccine against cervical and other HPV cancers, in which Kentucky leads U.S.
BY MELISSA PATRICK KENTUCKY HEALTH NEWS Kentucky leads the nation in the rate of cases of and deaths from cervical cancer, a disease that is largely preventable by a vaccine. The vaccine targets the human papillomavirus, which can cause cancers of the cervix, genitals, anus, neck and head. Kentucky also leads the nation in cancers…
-
FDA approves first-ever RSV vaccine for people 60 and older
BY MELISSA PATRICK KENTUCKY HEALTH NEWS People 60 and older now have access to the first approved vaccine against respiratory syncytial virus. The vaccine, developed by GlaxoSmithKline, is called Arexvy and was approved May 3 by the Food and Drug Administration. “Today’s approval of the first RSV vaccine is an important public-health achievement to prevent…